Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

Digital Health Roundup: CE Mark For Vision-Restoring Implant, AI Chatbot Rules, MS Deal

6 August 2026 · By · Wire by Fusion42

Published

6 August 2026

Topic

opportunities

◆ Sectors

Digital Health

◆ Geography

Europe

◆ Source

Read at insights.citeline.com →

◆ Verified

Fusion42 · 6 August 2026 · Fusion42 review

Science Corp's vision-restoring brain-computer interface (PRIMA) has received CE mark approval for use in AMD patients in Europe, and collaborations involving AI in neurodegenerative disease care and mental health chatbot regulation are progressing.

This Wire brief sits within Fusion42's coverage of Digital Health.

◆ ◆ The Wire takeaway

You must prepare for new EU market demands as vision-restoring implants gain CE mark approval, opening clinical use pathways in Germany and the UK. Mental health chatbot developers face incoming US regulation demands, altering deployment and marketing strategies.

◆ Coverage

1 source · 6 Aug 2026

◆ Related on Wire

◆ Topics

Digital Healthbrain-computer-interfacece-markmental-health-aineurodegenerative-diseasems-trackingus-regulation